MRNA paring some of yesterday’s gain, down 12% premarket
MRNA is paring some of yesterday’s gain, with the stock down 12% in premarket trading, according to Hammerstone MarketTalk; no catalyst was supplied.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.